Selected article for: "cc NC International license and RNA synthesis"
Author: Yadi Zhou; Yuan Hou; Jiayu Shen; Yin Huang; William Martin; Feixiong Cheng
Title: Network-based Drug Repurposing for Human Coronavirus
  • Document date: 2020_2_5
    • ID: b4mdiont_43
    Snippet: Sirolimus, an inhibitor of mTOR with both antifungal and antineoplastic properties, has demonstrated to improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure [47] . The mTOR signaling plays an essential role for MERS-CoV infection [62] . Dactinomycin, also known actinomycin D, is an approved RNA synthesis inhibitor for treatment of various cancer . CC-BY-NC 4.0 International license It is made available under a au.....
    Document: Sirolimus, an inhibitor of mTOR with both antifungal and antineoplastic properties, has demonstrated to improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure [47] . The mTOR signaling plays an essential role for MERS-CoV infection [62] . Dactinomycin, also known actinomycin D, is an approved RNA synthesis inhibitor for treatment of various cancer . CC-BY-NC 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory failure and cc NC International license: 1, 2
    • acute respiratory failure and essential role: 1
    • acute respiratory failure and H1N1 pneumonia: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory failure and International license: 1, 2, 3
    • acute respiratory failure and mTOR inhibitor: 1, 2
    • acute respiratory failure and mtor signaling: 1
    • acute respiratory failure and outcome improve: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute respiratory failure and severe H1N1 pneumonia: 1, 2, 3
    • cancer treatment and cc NC International license: 1, 2, 3
    • cancer treatment and essential role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cancer treatment and International license: 1, 2, 3, 4
    • cancer treatment and mTOR inhibitor: 1, 2
    • cancer treatment and outcome improve: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • cc NC International license and essential role: 1, 2, 3
    • cc NC International license and H1N1 pneumonia: 1
    • cc NC International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC International license and mTOR inhibitor: 1
    • cc NC International license and severe H1N1 pneumonia: 1
    • essential role and International license: 1, 2, 3, 4, 5